{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:37:10Z","timestamp":1774535830115,"version":"3.50.1"},"reference-count":31,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.11112","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:43:07Z","timestamp":1574163787000},"source":"Crossref","is-referenced-by-count":5,"title":["Nomogram construction for predicting survival of patients with non\u2011small cell lung cancer with malignant pleural or pericardial effusion based on SEER analysis of 10,268\ufffdpatients"],"prefix":"10.3892","author":[{"given":"Tian","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengpeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Imaging Center, Fuyang Second People's Hospital, Fuyang, Anhui 236000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiling","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"key20200714095938_b1-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"key20200714095938_b2-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"key20200714095938_b3-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000489315","article-title":"An observational study evaluating the performance of LENT score in the selected population of malignant pleural effusion from lung adenocarcinoma in Singapore","volume":"96","author":"Abisheganaden","year":"2018","journal-title":"Respiration"},{"key":"key20200714095938_b4-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/JTO.0b013e318164545d","article-title":"Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California cancer registry","volume":"3","author":"Ou","year":"2008","journal-title":"J Thorac Oncol"},{"key":"key20200714095938_b5-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British thoracic society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"key20200714095938_b6-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): A multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"key":"key20200714095938_b7-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"key20200714095938_b8-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5830\/CVJA-2011-029","article-title":"The value of serum tumour markers in the prediction of aetiology and follow up of patients with pericardial effusion","volume":"23","author":"Bildirici","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"key20200714095938_b9-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","article-title":"Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer","volume":"29","author":"Wang","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200714095938_b10-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/cncr.28447","article-title":"Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: A SEER-Medicare analysis","volume":"120","author":"Eil","year":"2014","journal-title":"Cancer"},{"key":"key20200714095938_b11-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jclinepi.2004.06.017","article-title":"Substantial effective sample sizes were required for external validation studies of predictive logistic regression models","volume":"58","author":"Vergouwe","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"key20200714095938_b12-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"key20200714095938_b13-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"key":"key20200714095938_b14-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"720","DOI":"10.21037\/tau.2016.09.07","article-title":"Predictive models and prognostic factors for upper tract urothelial carcinoma: A comprehensive review of the literature","volume":"5","author":"Mbeutcha","year":"2016","journal-title":"Transl Androl Urol"},{"key":"key20200714095938_b15-ol-0-0-11112","doi-asserted-by":"crossref","first-page":"66784","DOI":"10.18632\/oncotarget.18158","article-title":"Evaluation of the 7th and 8th editions of the AJCC\/UICC TNM staging systems for lung cancer in a large North American cohort","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"key20200714095938_b16-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"e22901","DOI":"10.1002\/jcla.22901","article-title":"Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion","volume":"33","author":"Tian","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"key20200714095938_b17-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: From bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"key20200714095938_b18-ol-0-0-11112","first-page":"143","article-title":"Influencing factors and combined application of chemiluminescence immunoassay for detection of tumor markers","volume":"1","author":"Liu","year":"2019","journal-title":"Clin Lab J"},{"key":"key20200714095938_b19-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12013-012-9384-8","article-title":"Analysis of driver mutations in female non-smoker Asian patients with pulmonary adenocarcinoma","volume":"64","author":"Ren","year":"2012","journal-title":"Cell Biochem Biophys"},{"key":"key20200714095938_b20-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"key":"key20200714095938_b21-ol-0-0-11112","first-page":"2892","article-title":"EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: A systematic review and global map by ethnicity (mutMapII)","volume":"5","author":"Midha","year":"2015","journal-title":"Am J Cancer Res"},{"key":"key20200714095938_b22-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1200\/JCO.2010.33.3757","article-title":"Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer","volume":"29","author":"Zhou","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200714095938_b23-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20200714095938_b24-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"e0132614","DOI":"10.1371\/journal.pone.0132614","article-title":"Visualizing risk prediction models","volume":"10","author":"Van Belle","year":"2015","journal-title":"PLoS One"},{"key":"key20200714095938_b25-ol-0-0-11112","first-page":"200","article-title":"Differentiation antigen expression and lung cancer heterogeneity","volume":"2","author":"Du","year":"2002","journal-title":"J Clin Exp Pathol"},{"key":"key20200714095938_b26-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1002\/cncr.29056","article-title":"Analysis of stage and clinical\/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system","volume":"120","author":"Chen","year":"2014","journal-title":"Cancer"},{"key":"key20200714095938_b27-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/0970-2113.201305","article-title":"Diagnosis and management options in malignant pleural effusions","volume":"34","author":"Dixit","year":"2017","journal-title":"Lung India"},{"key":"key20200714095938_b28-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"key":"key20200714095938_b29-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714095938_b30-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1200\/JCO.2015.63.3651","article-title":"Biomarker: Predictive or prognostic?","volume":"33","author":"Ballman","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20200714095938_b31-ol-0-0-11112","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.urology.2010.06.019","article-title":"Everything you always wanted to know about evaluating prediction models (but were too afraid to ask)","volume":"76","author":"Vickers","year":"2010","journal-title":"Urology"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:06:41Z","timestamp":1594721201000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.11112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.11112","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]}}}